BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 21, 2026; 32(23): 118240
Published online Jun 21, 2026. doi: 10.3748/wjg.v32.i23.118240
Endoscopic treatment of small bowel hemangiomas via double-balloon enteroscopy: A single-center comparative study
Wen-Bo Zhu, Hua-Bing Huang, Yi-Fan Qiu, Yuan-Hang Dong, Xin-Tong Zhao, Xian-Zhu Zhou, Zhao-Shen Li, Yi-Qi Du
Wen-Bo Zhu, Hua-Bing Huang, Yi-Fan Qiu, Yuan-Hang Dong, Xin-Tong Zhao, Xian-Zhu Zhou, Zhao-Shen Li, Yi-Qi Du, Department of Gastroenterology, The National Clinical Research Center for Digestive Diseases, Changhai Hospital, Shanghai 200433, China
Wen-Bo Zhu, Hua-Bing Huang, Yi-Fan Qiu, Yuan-Hang Dong, Xin-Tong Zhao, Xian-Zhu Zhou, Zhao-Shen Li, Yi-Qi Du, National Key Laboratory of Immunity and Inflammation, Naval Medical University, Shanghai 200433, China
Co-first authors: Wen-Bo Zhu and Hua-Bing Huang.
Co-corresponding authors: Zhao-Shen Li and Yi-Qi Du.
Author contributions: Zhu WB, Huang HB, Qiu YF, Dong YH, Zhao XT, Zhou XZ, Li ZS, and Du YQ contributed to the conceptualization and methodology of the study; Zhu WB and Huang HB contributed equally as co-first authors; Zhu WB, Huang HB, Qiu YF, and Dong YH performed the validation, formal analysis, investigation, data curation, and wrote the original draft; Zhao XT and Zhou XZ contributed to the software and visualization; Li ZS and Du YQ provided resources, supervised the project, and reviewed and edited the manuscript, contributed equally as co-corresponding authors; Du YQ was responsible for project administration. All authors read and approved the final version.
Supported by Shanghai Shenkang Hospital Development Center, No. SHDC2020CR5013.
Institutional review board statement: This study was approved by the Institutional Review Board of Changhai Hospital, No. CHEC2024-419.
Informed consent statement: Informed consent was obtained from all the patients enrolled in this study.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: The data that support the findings of this study are available from the corresponding author, upon reasonable request.
Corresponding author: Yi-Qi Du, MD, PhD, Department of Gastroenterology, The National Clinical Research Center for Digestive Diseases, Changhai Hospital, No. 168 Changhai Road, Yangpu District, Shanghai 200433, China. duyiqi007@163.com
Received: January 23, 2026
Revised: February 15, 2026
Accepted: March 20, 2026
Published online: June 21, 2026
Processing time: 135 Days and 18 Hours
Abstract
BACKGROUND

Previous studies have not clarified a universally acknowledged treatment approach that can eradicate small bowel hemangiomas while minimizing harm to patients. Although studies have indicated that endoscopic interventions have promising treatment effects with minimal invasiveness, no comparison of different types of endoscopic therapies has been conducted.

AIM

To compare the clinical efficacy, safety, and procedural outcomes of lauromacrogol injection, argon plasma coagulation (APC), and endoscopic ligation via double-balloon enteroscopy for the treatment of small bowel hemangiomas, and to identify lesion-specific optimal endoscopic strategies.

METHODS

Seventy-five participants were enrolled in this study. Thirteen patients received conservative treatment, 20 received lauromacrogol injection, 22 underwent APC, 18 underwent endoscopic ligation therapy, and two received hemostatic clip therapy. Key indicators and prognostic information for different treatment methods were compared between conservative-interventional and within interventional therapies. Categorical variables were compared using the χ2 or Fisher’s exact test, and continuous variables were compared using the Student’s t-test or Wilcoxon rank sum test.

RESULTS

Compared with conservative therapy, interventional therapy was associated with a lower rebleeding rate. Compared with ligation therapy, lauromacrogol therapy was associated with less intraprocedural bleeding and showed a higher technical success rate and shorter operative duration. Compared with lauromacrogol and ligation therapies, APC was associated with a shorter procedure duration, a higher technical success rate, and less intraprocedural bleeding.

CONCLUSION

Our observational data suggest that lauromacrogol injection may be a more suitable option for raised small bowel hemangiomas, while APC may be preferable for flat lesions.

Keywords: Small bowel hemangioma; Double-balloon enteroscopy; Lauromacrogol injection; Argon plasma coagulation; Endoscopic ligation; Obscure gastrointestinal bleeding

Core Tip: Small bowel hemangioma is a rare but important cause of obscure gastrointestinal bleeding, and the optimal endoscopic treatment strategy remains unclear. This single-center retrospective study is the first to compare lauromacrogol injection, argon plasma coagulation, and endoscopic ligation via double-balloon enteroscopy. Our findings suggest that lauromacrogol injection is safer and more effective for raised lesions, while argon plasma coagulation is the optimal option for flat hemangiomas, providing practical guidance for endoscopists in clinical decision-making.

Write to the Help Desk